Sustainability Statement Of Intent Our ESG Pathway

Overview

The report presents Mundipharma's first enterprise-wide sustainability communication, outlining ESG governance, social responsibility and environmental priorities. It describes the company's first double materiality assessment, conducted in 2024, and identifies climate change, workforce, value-chain and business-conduct issues as critical material topics. The environmental section reports 2024 Scope 1 emissions of 2,535 tCO2e, location-based Scope 2 emissions of 2,515 tCO2e and total location-based emissions of 6,169 tCO2e. It also sets out future actions, including expanding Scope 3 footprinting and publishing a more comprehensive CSRD-aligned ESG report in 2026.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services